Clinical Trials Directory

Trials / Completed

CompletedNCT04525482

Application of Early Goal-directed Sedation in Patients With Severe Brain Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

EGDS management strategy was implemented in ICU patients with severe brain injury, the depth of sedation and GCS score were monitored, and the protective effects of EGDS strategy and standard sedation strategy on the brain of patients with severe brain injury were discussed.

Conditions

Interventions

TypeNameDescription
OTHEREarly goal-directed sedation programsA. Provide sedation at the beginning of the titration of dextrometomidine; b. Optimize sedation when dextrometomidine is used alone and at a maximum dose not sufficient to provide comfort and safety to the patient and to achieve a level of sedation at any time specified by the treating physician. C. Provides immediate recovery and sedation, and can control sudden agitation at any time

Timeline

Start date
2017-01-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2020-08-25
Last updated
2020-08-25

Source: ClinicalTrials.gov record NCT04525482. Inclusion in this directory is not an endorsement.

Application of Early Goal-directed Sedation in Patients With Severe Brain Injury (NCT04525482) · Clinical Trials Directory